.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Farmers Insurance
Fuji
Express Scripts
Dow
McKesson
Teva
Daiichi Sankyo
QuintilesIMS
Argus Health

Generated: December 17, 2017

DrugPatentWatch Database Preview

Mechanism of Action: Calcium Chelating Activity

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
NovartisVOLTARENdiclofenac sodiumSOLUTION/DROPS;OPHTHALMIC020037-001Mar 28, 1991ATRXYesYes► Subscribe► Subscribe► Subscribe
Mission PharmaUROCIT-Kpotassium citrateTABLET, EXTENDED RELEASE;ORAL019071-001Aug 30, 1985ABRXYesNo► Subscribe► Subscribe► Subscribe
Mission PharmaUROCIT-Kpotassium citrateTABLET, EXTENDED RELEASE;ORAL019071-002Aug 31, 1992ABRXYesNo► Subscribe► Subscribe► Subscribe
Mission PharmaUROCIT-Kpotassium citrateTABLET, EXTENDED RELEASE;ORAL019071-003Dec 30, 2009ABRXYesYes► Subscribe► Subscribe► Subscribe
United GuardianRENACIDINcitric acid; gluconolactone; magnesium carbonateSOLUTION;IRRIGATION019481-001Oct 2, 1990RXYesYes► Subscribe► Subscribe► Subscribe
Ferring Pharms IncPREPOPIKcitric acid; magnesium oxide; sodium picosulfateFOR SOLUTION;ORAL202535-001Jul 16, 2012RXYesYes► Subscribe► SubscribeY► Subscribe
Ferring Pharms IncPREPOPIKcitric acid; magnesium oxide; sodium picosulfateFOR SOLUTION;ORAL202535-001Jul 16, 2012RXYesYes► Subscribe► SubscribeY► Subscribe
Zydus Pharms Usa IncPOTASSIUM CITRATEpotassium citrateTABLET, EXTENDED RELEASE;ORAL203546-002Aug 6, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncPOTASSIUM CITRATEpotassium citrateTABLET, EXTENDED RELEASE;ORAL203546-003Aug 6, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Strides PharmaPOTASSIUM CITRATEpotassium citrateTABLET, EXTENDED RELEASE;ORAL206813-001Sep 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Federal Trade Commission
Queensland Health
Covington
Express Scripts
Dow
Johnson and Johnson
Chinese Patent Office
Teva
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot